Brady L Stein Selected Research

Brady L Stein Research Topics

14	Neoplasms (Cancer) 12/2023 - 11/2011
8	Polycythemia Vera 12/2023 - 10/2011
8	Thrombosis (Thrombus) 07/2020 - 11/2011
6	Anemia 01/2023 - 10/2011
6	Primary Myelofibrosis (Myelosclerosis) 01/2023 - 10/2011
4	Hemorrhage 07/2020 - 11/2015
2	Splenomegaly 01/2023 - 01/2016
2	Systemic Mastocytosis 01/2021 - 12/2018
2	Eosinophilia 01/2020 - 01/2012
2	Venous Thrombosis (Deep-Vein Thrombosis) 12/2019 - 11/2019
2	Thrombocytosis (Thrombocythemia) 12/2014 - 10/2011
2	Polycythemia (Erythrocytosis) 12/2014 - 10/2011
2	Leukemia 11/2011 - 10/2011
1	acquired Thrombotic thrombocytopenic purpura 01/2023
1	Infections 01/2023
1	Weight Gain 01/2023
1	Thrombocytopenia (Thrombopenia) 01/2023
1	Skin Neoplasms (Skin Cancer) 01/2023
1	Thrombotic Thrombocytopenic Purpura 01/2023
1	Anaphylaxis (Anaphylactic Shock) 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Cytopenia 02/2015
1	Venous Thromboembolism 01/2015
1	Leukocytosis (Pleocytosis) 12/2014
1	Chronic Renal Insufficiency 01/2014
1	Altitude Sickness (Mountain Sickness) 04/2013
1	Splenic Infarction 05/2012
1	Infectious Mononucleosis (Glandular Fever) 05/2012
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 05/2012
1	Hemolytic Anemia 05/2012
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2011
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2011

5	ruxolitinibIBA 01/2023 - 11/2011
3	Janus Kinase InhibitorsIBA 01/2023 - 11/2011
2	N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA 01/2023 - 11/2011
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020 - 11/2015
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2015 - 02/2013
2	DNA (Deoxyribonucleic Acid)IBA 02/2015 - 10/2011
2	Small Interfering RNA (siRNA)IBA 08/2013 - 12/2012
1	TESIBA 12/2023
1	thiamine triphosphorate (TTP)IBA 01/2023
1	caplacizumabIBA 01/2023
1	11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA 01/2023
1	luspaterceptIBA 10/2021
1	avapritinibIBA 01/2021
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 01/2020
1	Syntex adjuvant formulationIBA 01/2018
1	CalreticulinIBA 06/2015
1	Antineoplastic Agents (Antineoplastics)IBA 04/2015
1	MethyltransferasesIBA 02/2015
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2015
1	Janus Kinase 2IBA 12/2014
1	Phosphotransferases (Kinase)IBA 08/2013
1	Interferon Type IIBA 08/2013
1	InterferonsIBA 04/2013
1	SaltsIBA 04/2013
1	Antiphospholipid AntibodiesIBA 05/2012
1	AutoantibodiesIBA 05/2012
1	Imatinib Mesylate (Gleevec)FDA Link 01/2012
1	fedratinibIBA 11/2011
1	CytokinesIBA 11/2011
1	Nonsense Codon (Nonsense Mutation)IBA 10/2011
1	Tyrosine Kinase InhibitorsIBA 09/2011